BREAKING: New research from the University of Bath in the UK has just confirmed safer consumption limits for cannabis, aiming to reduce the risk of cannabis use disorder (CUD). The study, published in the journal Addiction, proposes that adults should not exceed 8 THC units per week—equivalent to about 40 mg of THC or one-third gram of herbal cannabis.
This groundbreaking approach mirrors guidelines for alcohol consumption, helping users monitor their intake based on THC content rather than weight. The researchers, led by Dr. Rachel Lees Thorne and Professor Tom Freeman, emphasize the importance of these thresholds as a tool for both users and public health officials.
According to their findings, exceeding 8 THC units significantly increases the risk of developing CUD, a condition impacting an estimated 22% of regular cannabis users. Furthermore, the risk escalates sharply beyond 13 THC units per week. The research highlights that 80% of users below the 8 THC unit mark did not experience CUD symptoms, while 70% of those exceeding this limit reported issues.
Dr. Thorne stated, “The ultimate goal of our new guidelines is to reduce harm. The only truly safe level of cannabis use is no use. However, for those who don’t want to stop or cannot, we want to make it easier for them to lower their risk.” This initiative aims to provide evidence-based advice for making informed choices about cannabis consumption.
The study draws on data from the CannTeen study at UCL, which tracked cannabis use among 150 participants over a year, assessing their THC intake and the severity of CUD. As cannabis legalization expands globally, the need for clear consumption guidelines becomes increasingly critical.
Professor Freeman emphasized, “Safer use thresholds based on standard THC units could help people better understand their level of use and make informed choices about their health.” The research is already gaining traction, particularly in countries like Canada, where there are ongoing discussions about including THC unit information on cannabis product labels—similar to alcohol labeling in the UK.
Dr. Robert Gabrys, a senior analyst at the Canadian Center on Substance Use and Addiction, added that the expert panel reviewing Canada’s Cannabis Act prioritizes developing a ‘standard dose’ for cannabis products. He noted, “Cannabis legalization in Canada has brought a much wider range of products to the market. Many people face challenges in understanding product labels and dosing safely.”
As the conversation surrounding cannabis use evolves, researchers at the University of Bath plan to expand their study, exploring safer cannabis thresholds in international contexts and developing tools to assist consumers in tracking their THC intake.
The implications of these findings are profound. With cannabis use becoming more prevalent, the establishment of safer consumption thresholds could significantly impact public health strategies and individual choices. The urgency for consumers to understand their cannabis use, as outlined in this research, cannot be overstated.
For those interested in making informed decisions about cannabis consumption, this new framework offers a critical step towards reducing risks associated with cannabis use. The research promises to shape future health policies and consumer education in the growing cannabis market.
Stay tuned for more updates as this story develops.
